CHRU Hopital Claude Huriez

Lile Cedax 59037

0 studies enrolling now · 2 studies all time

What they study most

Malignant Melanoma, Multiple Myeloma

Studies at this site

• A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma — Running, not enrolling
• A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma — Completed